Martin Samuel Bates

Martin Samuel Bates's trades of Celldex Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-18 2024-06-14
S Sale
17,172 -37.9%
35.42
USD 608,315 		17,172 -37.9% 35.42 USD 608,315
2024-06-03 2024-05-30
S Sale
35,000 -58.2%
34.05
USD 1,191,775 		35,000 -58.2% 34.05 USD 1,191,775
2022-08-15 2022-08-12
S Sale
1,221 -4.8%
34.62
USD 42,272 		1,221 -4.8% 34.62 USD 42,272
2022-08-15 2022-08-12
S Sale
2,065 -7.5%
35.38
USD 73,053 		2,065 -7.5% 35.38 USD 73,053
2022-08-15 2022-08-12
S Sale
14,261 -34.0%
36.76
USD 524,304 		14,261 -34.0% 36.76 USD 524,304
2022-08-15 2022-08-11
S Sale
2,453 -9.1%
37.04
USD 90,856 		2,453 -9.1% 37.04 USD 90,856
2021-11-17 2021-11-15
PS Planned sale
2,048 -7.1%
42.27
USD 86,569 		2,048 -7.1% 42.27 USD 86,569
2021-11-17 2021-11-15
PS Planned sale
7,452 -20.5%
43.92
USD 327,314 		7,452 -20.5% 43.92 USD 327,314
2020-06-10 2020-06-09
PP Planned purchase
9,750 +989.8%
3.05
USD 29,738 		9,750 +989.8% 3.05 USD 29,738
// ... existing code ... // ... rest of the file ...